HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naoki Mori Selected Research

Radiotherapy

10/2020Argon plasma coagulation for superficial squamous cell carcinoma in the residual esophagus after esophagectomy.
7/2015[Primary Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma with Large Cell Transformation of the Prostate : A Case Report].
1/2011[Bladder preservation using chemoradiation therapy for locally invasive bladder cancer].
6/2009Four cases of advanced renal cell carcinoma with pancreatic metastasis successfully treated with radiation therapy.
4/2007[A case of retroperitoneal malignant fibrous histiocytoma with marked response to concurrent cisplatin and radiation therapy: a case report].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naoki Mori Research Topics

Disease

55Neoplasms (Cancer)
12/2023 - 02/2002
39Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
04/2024 - 02/2002
29T-Cell Leukemia (Leukemia, T Cell)
04/2024 - 02/2002
18Infections
04/2024 - 05/2003
10Neoplasm Metastasis (Metastasis)
10/2020 - 02/2002
10Lymphoma (Lymphomas)
01/2019 - 01/2002
9Carcinogenesis
07/2010 - 01/2003
5Carcinoma (Carcinomatosis)
04/2024 - 09/2009
5Esophageal Neoplasms (Esophageal Cancer)
04/2024 - 01/2005
5Urinary Bladder Neoplasms (Bladder Cancer)
01/2018 - 06/2002
5Prostatic Neoplasms (Prostate Cancer)
04/2014 - 08/2004
5Hodgkin Disease (Hodgkin's Disease)
12/2012 - 03/2006
5Burkitt Lymphoma (Burkitt's Lymphoma)
10/2012 - 01/2006
4Fatigue
10/2021 - 04/2006
4Leukemia
03/2021 - 04/2008
4Primary Effusion Lymphoma
01/2021 - 01/2011
4Retinal Degeneration
03/2007 - 02/2002
3Stroke (Strokes)
07/2023 - 01/2021
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2021 - 11/2007
3Melanoma (Melanoma, Malignant)
10/2021 - 04/2003
3Acquired Immunodeficiency Syndrome (AIDS)
11/2020 - 01/2006
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2020 - 01/2005
3Atrial Fibrillation
10/2019 - 08/2013
3Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
04/2018 - 12/2008
3Adenocarcinoma
01/2017 - 06/2002
3Fever (Fevers)
03/2015 - 07/2011
3Osteosarcoma (Osteogenic Sarcoma)
10/2013 - 08/2011
3Tetraploidy
04/2013 - 10/2004
3Hepatocellular Carcinoma (Hepatoma)
05/2012 - 03/2006
3T-Cell Lymphoma (Lymphoma, T Cell)
07/2011 - 01/2003
3Renal Cell Carcinoma (Grawitz Tumor)
06/2011 - 06/2009
2Fistula
04/2024 - 01/2017
2Virus Diseases (Viral Diseases)
04/2024 - 05/2012
2Polycythemia Vera
01/2023 - 07/2008
2Esophageal Squamous Cell Carcinoma
08/2021 - 10/2020
2Hemorrhage
10/2019 - 01/2016
2Ascites
11/2017 - 09/2013
2Acute Coronary Syndrome
01/2017 - 02/2014
2Thrombosis (Thrombus)
01/2017 - 01/2016
2Myocardial Infarction
01/2017 - 02/2014
2Carcinoma in Situ
04/2014 - 04/2013
2Fibrosis (Cirrhosis)
10/2013 - 05/2012
2Inflammation (Inflammations)
08/2013 - 02/2009

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
08/2017 - 02/2002
17NF-kappa B (NF-kB)IBA
01/2010 - 09/2002
10DNA (Deoxyribonucleic Acid)IBA
01/2023 - 02/2003
7Oncogene Proteins (Oncogene Protein)IBA
04/2024 - 03/2004
6Messenger RNA (mRNA)IBA
01/2022 - 01/2003
6Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2021 - 03/2006
6fucoidanIBA
11/2017 - 01/2005
5Phosphotransferases (Kinase)IBA
12/2020 - 08/2017
5LigandsIBA
12/2015 - 02/2005
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2021 - 07/2007
4Prednisolone (Predate)FDA LinkGeneric
01/2021 - 07/2007
4Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 07/2007
4Cisplatin (Platino)FDA LinkGeneric
01/2018 - 01/2007
4Polysaccharides (Glycans)IBA
11/2017 - 01/2005
4fucoxanthinIBA
10/2013 - 12/2008
4fucoxanthinolIBA
10/2013 - 12/2008
3Rituximab (Mabthera)FDA Link
01/2021 - 09/2011
3Janus KinasesIBA
10/2018 - 04/2006
3CytokinesIBA
01/2012 - 04/2006
3Matrix Metalloproteinases (MMPs)IBA
08/2011 - 02/2002
3Aurora Kinase BIBA
05/2011 - 05/2010
3NF-KappaB Inhibitor alphaIBA
05/2007 - 02/2006
3CurcuminIBA
04/2006 - 02/2006
2Indicators and Reagents (Reagents)IBA
05/2024 - 04/2023
2AcidsIBA
07/2023 - 09/2015
2AntigensIBA
10/2021 - 05/2003
2LipidsIBA
08/2021 - 10/2013
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
08/2021 - 07/2011
2ArtesunateIBA
01/2021 - 04/2020
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 07/2015
2Histone Deacetylase InhibitorsIBA
12/2020 - 05/2004
2AnticoagulantsIBA
10/2019 - 01/2016
2R-CHOP protocolIBA
01/2019 - 09/2011
2Hormones (Hormone)IBA
03/2018 - 01/2012
2Interleukin-2 (IL2)IBA
08/2017 - 07/2009
2C-Reactive ProteinIBA
11/2015 - 08/2013
2EnzymesIBA
03/2015 - 07/2008
2Estrogens (Estrogen)FDA Link
04/2014 - 04/2004
2hippuristanolIBA
09/2013 - 03/2011
2InterferonsIBA
09/2013 - 06/2011
2Anti-Bacterial Agents (Antibiotics)IBA
06/2013 - 03/2005

Therapy/Procedure

32Therapeutics
01/2022 - 09/2004
11Drug Therapy (Chemotherapy)
01/2018 - 01/2006
8Esophagectomy
04/2024 - 01/2005
5Radiotherapy
10/2020 - 04/2007
4Cystectomy
01/2018 - 01/2011
4Prostatectomy (Retropubic Prostatectomy)
09/2004 - 10/2003
3Chemoradiotherapy
04/2024 - 01/2005
3Activities of Daily Living (ADL)
01/2022 - 01/2021
3Aftercare (After-Treatment)
10/2020 - 05/2012
3Nephrectomy
08/2009 - 06/2009
2Immunotherapy
08/2021 - 04/2013
2Stents
01/2017 - 01/2016
2Catheters
01/2017 - 04/2013
2Urinary Diversion (Ileal Conduit)
01/2017 - 04/2014
2Adjuvant Chemotherapy
11/2015 - 09/2010
2Pancreaticoduodenectomy
03/2015 - 08/2012